Analysts Viewpoint
Analysts review Pliant Therapeutics Inc’s rating
Pliant Therapeutics Inc’s recent filing unveils that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million
Menu
Pliant Therapeutics Inc’s recent filing unveils that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million
Pliant Therapeutics Inc’s recent filing unveils that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Pliant Therapeutics Inc’s recently made public that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Pliant Therapeutics Inc revealed its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pliant Therapeutics
Pliant Therapeutics Inc’s filing revealed that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million on